Navigation Links
HFSP research funding for the Helmholtz Zentrum München
Date:3/27/2014

The Human Frontier Science Program (HFSP) funds innovative research work in the field of life sciences. The organization's members are Australia, Canada, France, Germany, Great Britain, India, Italy, Japan, New Zealand, Norway, South Korea, Switzerland and the USA, as well as the EU. Research grants are awarded to international research collaborations that carry out interdisciplinary work in order to develop cutting edge approaches to fundamental issues in the life sciences.

Oxidized lipidomes: Key figures in non-apoptotic cell death

Oxidative modifications of lipids are a key process in non-apoptotic cell death signalling and play important roles in a number of relevant diseases, such as neurodegeneration, diabetes and asthma. A team of scientists headed by Dr. Marcus Conrad from the Institute of Developmental Genetics (IDG) at the Helmholtz Zentrum Mnchen (HMGU) now strives to intensify research into the underlying molecular mechanisms. The overall goal of this program is to identify the specific signature of oxidized lipids and to decipher the interaction of these modified lipids with signal molecules that ultimately promote non-apoptotic cell death. Knowledge gained by this approach should lead to the development of a language code that, in turn, may provide cues for the design of novel treatment strategies. The partners in the project are Dr. Valerian Kagan, University of Pittsburgh (USA), Dr. Fulvio Ursini, University of Padova (Italy) and Dr. Judith Klein-Seetharaman, Warwick Medical School, Coventry (UK).

Mechanosensation: transmission and perception of neuronal stimuli

Movement and coordination must be modulated according to the environment. They are subject to permanent feedback from the perceived stimuli and adequate adaptive responses. With respect to the perceived signals, it is necessary to distinguish between external influences and self-generated stimuli a capability that makes highly differentiated motor sequences possible. The scientists headed by Dr. Hrnan Lpez-Schier from the Sensory Biology and Organogenesis (SBO) research unit at the HMGU want to uncover the underlying mechanosensation circuits and precisely characterize the involved nerve cells and genes. Partners in the project are Prof. Florian Engert, Harvard University (USA) and Dr. Ana Belen Elgoyhen, INGEBI-CONICET in Buenos Aires (Argentina).


'/>"/>

Contact: Press Office
presse@helmholtz-muenchen.de
49-893-187-2711
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related biology news :

1. UGA researchers explore function of cancer-causing gene
2. CASIS-sponsored research heads to space station aboard SpaceX-3
3. Distinguished researcher to speak at NJIT on preventing bone loss
4. Researchers present comprehensive roadmap of blood cells
5. Research produces strong evidence for a new class of antidepressant drugs
6. UT Southwestern ob/gyn researchers studying genetic factors in premature births
7. Researchers issue state-of-the-state on genetic-based testing & treatment for breast cancer
8. Deep ocean current may slow due to climate change, Penn research finds
9. NIH grants up to $28 million to group led by Scripps Research for work on ebola treatment
10. Heidelberg researcher awarded Animal Welfare Prize of the German Research Foundation
11. Jump start for frontier projects: The 2014 HFSP Research Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: